Combined effect of serum alanine aminotransferase and gamma-glutamyltransferase on incidence of diabetes mellitus: A longitudinal study.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
entrez:
17
3
2020
pubmed:
17
3
2020
medline:
24
3
2020
Statut:
ppublish
Résumé
High levels of serum alanine aminotransferase (ALT) and gamma-glutamyltransferase (GGT) are associated with increased diabetes risk. In the present study, we investigated the combined effects of ALT and GGT on the development of diabetes in a Korean population. A total of 9405 individuals (4020 women and 5385 men) without diabetes were enrolled in this study. From the baseline health screening to the follow-up examination, the development of diabetes, based on changes in ALT and GGT quartile levels, was analyzed. In addition, we analyzed the quartiles of ALT and GGT together to determine any synergistic effect from the fourth quartile of ALT and GGT on the development of diabetes. The development of diabetes gradually increased with an increase in the circulating levels of ALT and GGT. For the fourth quartile ALT and GGT, the hazard ratios of diabetes compared with the first quartile were 1.892 (95% confidence interval [CI]: 1.26-2.83, P = .002) and 3.526 (95% CI: 2.12-5.85, P < .001) after adjusting for confounders, respectively. Hazard ratios of diabetes after combining both fourth quartiles of ALT and GGT were 3.663 (95% CI: 2.42-5.52, P < .001), as compared with the first and second quartiles. Serum ALT and GGT levels are well associated with diabetes in Koreans after adjusting for confounders, and a combination of ALT and GGT levels can have a synergy in predicting the development of diabetes.
Identifiants
pubmed: 32176028
doi: 10.1097/MD.0000000000018963
pii: 00005792-202003130-00005
pmc: PMC7440152
doi:
Substances chimiques
Biomarkers
0
gamma-Glutamyltransferase
EC 2.3.2.2
Alanine Transaminase
EC 2.6.1.2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e18963Références
Atherosclerosis. 2006 Nov;189(1):198-205
pubmed: 16405892
Diabetes. 2002 Jun;51(6):1889-95
pubmed: 12031978
Am J Epidemiol. 2013 Jul 15;178(2):159-71
pubmed: 23729682
Diabetologia. 2003 Mar;46(3):359-64
pubmed: 12687334
Hepatology. 2012 Mar;55(3):968-70
pubmed: 22362600
Indian J Med Res. 2016 Apr;143(4):389-91
pubmed: 27377490
J Subst Abuse. 2000;12(1-2):33-49
pubmed: 11288473
Ann Hepatol. 2019 Mar - Apr;18(2):298-303
pubmed: 31040092
J Clin Invest. 1997 Jan 1;99(1):144-50
pubmed: 9011569
Diabetes Care. 2012 Apr;35(4):717-22
pubmed: 22338098
Can J Diabetes. 2018 Dec;42(6):652-658
pubmed: 29936075
Diabetes Care. 2007 Oct;30(10):2566-8
pubmed: 17626893
Prev Cardiol. 2010 Winter;13(1):36-41
pubmed: 20021625
Hum Mol Genet. 2016 Sep 1;25(17):3877-3886
pubmed: 27466193
Nat Clin Pract Nephrol. 2005 Dec;1(2):80-6
pubmed: 16932373
Diabetes Metab Res Rev. 2001 May-Jun;17(3):189-212
pubmed: 11424232
Diabetes Care. 2011 Dec;34(12):2603-7
pubmed: 21953798
World J Gastroenterol. 2015 Jun 28;21(24):7478-87
pubmed: 26139993
Ann Epidemiol. 2018 Oct;28(10):675-680.e6
pubmed: 30075987
Clin Chem. 2003 Aug;49(8):1358-66
pubmed: 12881453
Gut. 1997 Dec;41(6):845-50
pubmed: 9462221
Diabetes Care. 2009 Apr;32(4):741-50
pubmed: 19131466